WellDyneRx, an independent Pharmacy Benefit Manager involved in delivering solutions through integrated data and technology, has named Jeff Park as its new chairman and chief executive officer of the company, it was reported yesterday.
Park is the former executive vice president and chief operating officer of Catamaran, which is now called optumRx. During his tenure, Catamaran grew from USD55m in revenues to a Fortune 500 public company with over USD21bn in revenues before it was acquired by United Health Group in 2015.
WellDyneRx lead director, Eric Elliott, said, 'We are excited to have Jeff join WellDyneRx president, Zach Johnson, and the rest of our leadership team. Jeff's strategic vision and operating expertise support our growth plans. Our extensive search for the right executive produced a great result. Now, with a strong team in place, we expect our value proposition in the constantly changing PBM sector to resonate even more clearly, and growth will accelerate.'
Lilly declares Q2 2025 dividend
Bruker acquires majority stake in RECIPE to expand clinical mass spectrometry diagnostics
Emmaus Life Sciences reports drop in revenues, increased loss in 2024
L'Oréal and WHO Foundation partner to expand global skin health access